Receptor-mediated therapeutic transport across the blood-brain barrier

Immunotherapy
Yun-Yan WangJian Yi Li

Abstract

The blood-brain barrier (BBB) hinders drug delivery to the brain parenchyma. The ultimate goal of brain drug targeting technology is to deliver therapeutics across the BBB with a diverse collection of molecular transport systems. Receptor-mediated transcytosis (RMT) is one such class of transport system. Insulin and transferrin, as well as other endogenous peptides, employ the vesicular trafficking machinery of the endothelium to transport substances between the blood and the brain. In addition to vector development, strategies for coupling drugs to the vector that give high-efficiency coupling are the other important element for RMT. After the BBB-targeting vector-therapeutic conjugates have crossed the BBB, there may still be a need to target them to a specific population of cells in the brain. This review will focus on two major aspects of RMT brain drug delivery: new advances of existing RMT systems and development of new BBB transport vectors and specific RMT targets.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P M FridenR M Starzyk
Jun 1, 1985·Journal of Neurochemistry·W M PardridgeJ Yang
Jul 1, 1986·Annals of Internal Medicine·W M PardridgeH J Frank
Feb 1, 1988·Metabolism: Clinical and Experimental·K R DuffyR G Rosenfeld
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R C Speth, S I Harik
Sep 1, 1987·Metabolism: Clinical and Experimental·W M PardridgeJ Yang
Jan 1, 1987·Journal of Neuroscience Research·J B FishmanR E Fine
Nov 8, 1984·Nature·W A JefferiesD Y Mason
Sep 1, 1995·The Journal of Clinical Investigation·S K MoestrupE I Christensen
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·S U ShinS L Morrison
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J HuwylerW M Pardridge
Nov 13, 1998·Journal of Pharmaceutical Sciences·R J BoadoW M Pardridge
Mar 6, 1999·The Journal of Biological Chemistry·C FillebeenA Pierce
Aug 17, 1999·Annual Review of Nutrition·M M HussainA Bakillah
Feb 26, 2000·Cellular and Molecular Neurobiology·T Moos, E H Morgan
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·N ShiW M Pardridge
Jan 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J Y LiW M Pardridge
Mar 22, 2001·Advanced Drug Delivery Reviews·U BickelW M Pardridge
Mar 23, 2001·Anti-cancer Drugs·M MazelJ Temsamani
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·N ShiW M Pardridge
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Arumugam MuruganandamDanica Stanimirovic
Feb 2, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hwa Jeong LeeWilliam M Pardridge
Mar 14, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Eric V ShustaWilliam M Pardridge
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Bi-Wei SongWilliam M Pardridge
Jul 4, 2002·Molecular & Cellular Proteomics : MCP·Eric V ShustaWilliam M Pardridge
Jul 20, 2002·Journal of Neuropathology and Experimental Neurology·Eric V ShustaWilliam M Pardridge
Aug 8, 2002·Journal of Drug Targeting·Christophe RousselleJean-Michel Scherrmann
Nov 8, 2002·Journal of Neurochemistry·Michel DemeuleRichard Béliveau
Nov 14, 2002·Pharmacological Reviews·Zhong Ming QianKwokping Ho

❮ Previous
Next ❯

Citations

Mar 21, 2012·Expert Opinion on Drug Metabolism & Toxicology·Xiaoying ChenWei-Chiang Shen
Feb 9, 2016·Journal of Pharmaceutical Sciences·Maria GregoriEmanuela Cazzaniga
Jan 26, 2013·International Journal of Pharmaceutics·Qing LvJian-Qing Gao
Jun 3, 2011·Brain Research·Svitlana Garbuzova-DavisPaul R Sanberg
Jan 17, 2015·Organic & Biomolecular Chemistry·Gregory R NaumiecBrenton DeBoef
Jan 1, 2016·BioImpacts : BI·Jaleh BararYadollah Omidi
Jan 10, 2017·Frontiers in Neuroscience·Caleb W Grote, Douglas E Wright
Oct 6, 2020·Macromolecular Bioscience·Anna E CaprificoGianpiero Calabrese
Sep 3, 2020·International Journal of Pharmaceutics·Bruno Fonseca-Santos, Marlus Chorilli

❮ Previous
Next ❯

Methods Mentioned

BETA
confocal microscopy
transgenic
RAP
surface
surface display
PCR

Software Mentioned

NeuroTrans

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

© 2021 Meta ULC. All rights reserved